Variant report
Variant | esv3431529 |
---|---|
Chromosome Location | chr4:90823257-90824134 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:90817680..90820518-chr4:90823255..90825762,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537867393 | chr4:90823266-90823267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369229006 | chr4:90823272-90823273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78868935 | chr4:90823273-90823274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs59943783 | chr4:90823275-90823276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs199862963 | chr4:90823276-90823277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs66485472 | chr4:90823277-90823278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371238326 | chr4:90823315-90823316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556565566 | chr4:90823333-90823334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571591329 | chr4:90823338-90823339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112249493 | chr4:90823340-90823341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576616424 | chr4:90823345-90823346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538917528 | chr4:90823369-90823370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572573151 | chr4:90823477-90823478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368146164 | chr4:90823478-90823479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554052488 | chr4:90823486-90823487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143698658 | chr4:90823509-90823510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181395347 | chr4:90823533-90823534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544145790 | chr4:90823568-90823569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72657801 | chr4:90823569-90823570 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs554379795 | chr4:90823599-90823600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148843502 | chr4:90823711-90823712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145376986 | chr4:90823733-90823734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564518369 | chr4:90823797-90823798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186505570 | chr4:90823843-90823844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545291741 | chr4:90823869-90823870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550429536 | chr4:90823926-90823927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560789903 | chr4:90823961-90823962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527889061 | chr4:90823979-90823980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549519825 | chr4:90824000-90824001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190168525 | chr4:90824031-90824032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181719329 | chr4:90824036-90824037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114884773 | chr4:90824050-90824051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114316208 | chr4:90824078-90824079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:90820000-90827600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:90822200-90827200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:90822400-90826000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr4:90822800-90830600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
5 | chr4:90823000-90824600 | Enhancers | HUVEC | blood vessel |
6 | chr4:90823000-90825600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr4:90823000-90830400 | Weak transcription | Primary hematopoietic stem cells | blood |
8 | chr4:90823200-90825000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |